A detailed history of Wpg Advisers, LLC transactions in Repligen Corp stock. As of the latest transaction made, Wpg Advisers, LLC holds 99 shares of RGEN stock, worth $14,724. This represents 0.01% of its overall portfolio holdings.

Number of Shares
99
Previous 121 18.18%
Holding current value
$14,724
Previous $15.4 Million 20.02%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

SELL
$108.89 - $145.23 $2,395 - $3,195
-22 Reduced 18.18%
99 $12.3 Million
Q1 2025

May 15, 2025

BUY
$127.24 - $174.24 $1,526 - $2,090
12 Added 11.01%
121 $15.4 Million
Q4 2024

May 15, 2025

BUY
$123.41 - $160.92 $13,451 - $17,540
109 New
109 $15.7 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.25B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wpg Advisers, LLC Portfolio

Follow Wpg Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wpg Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wpg Advisers, LLC with notifications on news.